Navigation Links
Reportlinker Adds Biomarkers - Technologies, Markets and Companies
Date:6/3/2010

Inhibition of influenza virus by siRNAs 95

Limitations of RNAi approach to influenza 96

Challenges and future prospects of siRNAs for influenza 96

Antisense approaches 97

NEUGENE® antisense for inhibition of multiple strains of influenza A 97

Nanoviricides against influenza 97

Other innovative approaches 98

Abatacept 98

Polymeric coatings to inactivate influenza virus 98

Cytotoxic therapy 98

Cyanovirin 99

Fludase 99

Multiferon® 99

Pyrrolidine dithiocarbamate 100

T-705 100

Value of antivirals in preventing spread of influenza after exposure 100

Resistance to influenza therapy and efforts to overcome it 100

NIAID Centers of Excellence for research on pandemic influenza viruses 101

Research on influenza viruses at Bayer 101

Concluding remarks and future prospects 102

8. AIDS/HIV 103

Introduction 103

Epidemiology 103

Current concepts of pathomechanisms 103

Decoding the structure of an entire HIV genome 104

Pathogenesis of AIDS 104

Host-pathogen interactions that regulate HIV-1 replication 105

Visualization of the interaction of HIV-1 proteins with target cells 105

Genentic basis of
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Reportlinker Adds Future of Red Biotechnology in China
2. Reportlinker Adds The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration
3. Reportlinker Adds the Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
4. Reportlinker Adds SNP Genotyping and Analysis Markets
5. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
6. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
7. Reportlinker Adds Biotechnology Instrumentation - International Market Trends
8. Reportlinker Adds Microplate Instrumentation & Supplies - A Global Market Perspective
9. Reportlinker Adds Pharmacodynamic Assays
10. Reportlinker Adds Neurostimulation - A Global Market Perspective
11. Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... , May 21, 2015  The EveryLife Foundation ... (R-UT) and Amy Klobuchar (D-MN) ... Accelerating Cures & Treatments, or OPEN ACT. ... patient advocacy organizations, this bipartisan legislation promises to ... medicines to rare disease patients by incentivizing drug ...
(Date:5/21/2015)... 21, 2015  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced positive updated results from ... for the treatment of unresectable glioblastoma multiforme (GBM), ... multisite trial is designed to investigate the preliminary ... tumors have progressed following prior treatment with surgery, ...
(Date:5/21/2015)... 21, 2015 Veolia’s environmental monitoring ... North American distribution agreement with VWR to distribute ... With more than 160 years of experience, VWR, ... for laboratory and production facilities, has cultivated a ... differentiated services to enable science. Endetec’s TECTA™ ...
(Date:5/20/2015)... Wayland, MA (PRWEB) May 20, 2015 ... in history, especially for lawns. US Patented Pearl’s ... rescue for lawns around the country that are coming ... technology that addresses a number of major global concerns ... is the “non-grass” grass – the alternative to the ...
Breaking Biology Technology:Advocates Cheer Senate Leaders for Introducing Bipartisan Bill to Increase Number of Rare Disease Treatments 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Veolia’s TECTA™ B16 Instrument for E. Coli Detection is Offered Exclusively Through VWR 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2
... of discovery and safety services to, meet ... development community, BOSTON and CLEVELAND, Aug. 6 ... cell lines and,services for drug-discovery and development applications, ... lines available to researchers,through a new Web site: ...
... ... alternatives, WALTHAM, Mass., ... that the Company is focusing its,day-to-day operations exclusively on obtaining financing ... cash,resources, the Company,s employees were released from employment, except,for Shawn Cain, ...
... 5 Replidyne, Inc.,(Nasdaq: RDYN ) today announced its ... 30, 2008., Replidyne reported a net loss of $18.7 ... loss per basic and diluted common share of $0.69,per share, ... basic,common share or $1.65 per common share on a fully ...
Cached Biology Technology:ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 3Arbios Announces It Has Suspended Operations 2Arbios Announces It Has Suspended Operations 3Arbios Announces It Has Suspended Operations 4Arbios Announces It Has Suspended Operations 5Replidyne Announces Second Quarter 2008 Results From Operations 2Replidyne Announces Second Quarter 2008 Results From Operations 3Replidyne Announces Second Quarter 2008 Results From Operations 4Replidyne Announces Second Quarter 2008 Results From Operations 5Replidyne Announces Second Quarter 2008 Results From Operations 6Replidyne Announces Second Quarter 2008 Results From Operations 7
(Date:4/27/2015)... FORT LAUDERDALE, Fla. , Apr. 27, 2015 /PRNewswire/ ... provider of access control and security systems is pleased ... joined the company as a consultant and member of ... Bedore is widely known as a thought leader ... Socrates Distance Learning Technology Group, and has published studies ...
(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/9/2015)... JOSE, Calif. , April 9, 2015 ... human interface solutions, announced today that it will report ... on Thursday, April 23, 2015, after the close of ... for analysts and investors at 2:00 p.m. PT (5:00 ...   To participate on the live call, ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2
... Stanford University is subjecting chunks of rock to hellish conditions ... climate change. By exposing a handful of ... critical new data about the large-scale underground storage of carbon ... warming. "About 60 percent of the world,s ...
... with children embrace religious traditions for social and personal ... University at Buffalo -- The State University of New ... some atheist scientists want their children to know about ... about their own religious preferences. "Our research shows ...
... a key to weight loss a no-brainer. But now, ... couch potato, stretched out in front of the TV, can ... on the pounds. Such inactivity actually encourages the body ... Gefen of TAU,s Department of Biomedical Engineering. Along with his ...
Cached Biology News:AGU meeting: Stanford scientists subject rocks to hellish conditions to combat global warming 2AGU meeting: Stanford scientists subject rocks to hellish conditions to combat global warming 3AGU meeting: Stanford scientists subject rocks to hellish conditions to combat global warming 4Some atheist scientists with children embrace religious traditions, according to new Rice research 2'Just chill?' Relaxing can make you fatter 2
Request Info...
Superior homology search software - in all the flavours of blast, with increased sensitivity and speed. Free windows version for academic use....
... Services are uniquely positioned to ... current competitive environment. Invitrogens experts ... express, purify, and characterize proteins ... Studies, Activity Assays, X-ray Crystallography, ...
... Standard Tray (3 per pack), 1. ... and blot processing.Automated staining of Coomassie ... and nucleic acid analysis.Prepares blots for ... detection.Programmable control of protocol, solution, volume, ...
Biology Products: